Cell Therapy Manufacturing Market

Cellular treatment uses living cells to kill and regulate cancer cells. Cellular therapy, according to researcher, uses the cell itself as medicine, in place of pharmaceuticals. As an illustrative example, adoptive T-cell transfer, also known as adoptive cell therapy, is a procedure that involves removing cancer-killing T cells from the patient's blood, boosting their number in a lab, and then reintroducing them to the patient to bolster the immune system's fight against the illness.

The cell therapy market is expected to gain further traction, with evolving treatment options and rapid technological innovation in cell therapy. Fewer side effects, high effectiveness and potent action, and ability to cure the disease are some of the major advantages of cell therapy. Roswell Park, a cancer treatment center, treats specific types of leukemia and lymphoma with Kymriah (tisagenlecleucel), Tecartus (brexucabtagene autoleucel) and Yescarta (axicabtagene ciloleucel), and to treat multiple myeloma with Abecma (idecabtagene vicleucel). Cellular therapies may also be available through clinical trials for the treatment of Metastatic melanoma, Multiple myeloma, Neuroblastoma and synovial cell carcinoma, ovarian cancer, etc.

Market Dynamics

The increasing government initiatives for the advancement in the manufacturing of cell therapy is expected to fuel the market growth over the forecast period. For instance, on February 15, 2022, Brainstorm Cell Therapeutics Inc., a developer of adult stem cell therapeutics for neurodegenerative diseases, announced that the Brazilian Patent Office approved a patent Technology Type titled "A method of generating cells which secrete Brain Derived Neurotrophic Factor (BDNF), Glial Derived Neurotrophic Factor (GDNF), Hepatocyte Growth Factor (HGF) and Vascular Endothelial Growth Factor (VEGF), wherein said cells do not Secrete Nerve Growth Factor (NGF)".

Key features of the study:

• This report provides an in-depth analysis of the global cell therapy manufacturing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cell therapy manufacturing market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include WuXi AppTec, Inc., Lineage Cell Therapeutics, Inc., HEALIOS K.K., Lonza, Merck KGaA., Takara Bio Inc., Sumitomo Dainippon Pharma Co., LTD, Fujifilm Holdings Corporation, Thermo Fisher Scientific, Inc., Astellas Pharma Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global cell therapy manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell therapy manufacturing market

Detailed Segmentation:

• Global Cell Therapy Manufacturing Market, By Therapy Type:
  • Allogeneic Cell Therapy
  • Autologous Cell Therapy   
• Global Cell Therapy Manufacturing Market, By Technology Type:
  • Somatic Cell Technology
  • Cell ImmortalizationTechnology
  • Viral Vector Technology
  • Genome Editing Technology
  • Cell Plasticity Technology
  • 3D Technology
• Global Cell Therapy Manufacturing Market, By Source:
  • IPSC’s (Induced pluripotent stem cell)
  • Bone Marrow
  • Umbilical Cord
  • Adipose Tissue
  • Neural Stem
• Global Cell Therapy Manufacturing Market, By Application:
  • Musculoskeletal
  • Cardiovascular
  • Gastrointestinal
  • Neurological
  • Oncology
  • Dermatology
  • Others
• Global Cell Therapy Manufacturing Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • WuXi AppTec, Inc.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Lineage Cell Therapeutics, Inc.,
  • HEALIOS K.K.,
  • Lonza,
  • Merck KGaA.,
  • Takara Bio Inc.,
  • Sumitomo Dainippon Pharma Co., LTD.
  • Fujifilm Holdings Corporation
  • Thermo Fisher Scientific, Inc.
  • Astellas Pharma Inc.

“*” marked represents similar segmentation in other categories in the respective section.